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IS APPLIED BEHAVIORAL ANALYSIS EDUCATION,
MEDICINE, OR BOTH?: A STUDY OF THE FUNDING
CHALLENGES THAT ACCOMPANY AN AUTISM DIAGNOSIS
Yaakov Pollak*
I. INTRODUCTION
In the last fifty years or so, there has been an explosion in the rates
of Autism Spectrum Disorder (“ASD”) diagnoses.1 Fortunately, the
same time period has seen the development of a method to take on
this debilitating disorder—Applied Behavioral Analysis (“ABA”).2 This
method entails thorough analysis of behaviors, weeding out negative
aspects and encouraging good ones.3 As one would expect, this is a
costly endeavor unaffordable to anyone but the most well-off.4
ABA is perceived as lying on the intersection between medicine
and education.5 While this provides for two potential sources of
funding,6 the perception can hurt the cause by scattering responsibility
and reducing accountability. These sectors provide a pretext for each
other, leaving parents to fend for themselves with the deck stacked
against them. The educational system provides, in an unfocused
manner, the minimum required of it by the Individuals with
Disabilities Education Act (“IDEA”),7 and medical insurance can only
be relied upon when specific mandates are in place.8 What is needed

* J.D. candidate, 2017, Seton Hall University School of Law. This author would like to
extend his gratitude to Professor John J. Jacobi, the Dorothea Dix Professor of Health
Law & Policy and Faculty Director of The Center for Health & Pharmaceutical Law &
Policy at Seton Hall Law, for his advice and critique on this Comment from its
inception to its completion.
1
See infra notes 13–14 and accompanying text.
2
See infra note 45 and accompanying text.
3
See infra notes 47–48 and accompanying text.
4
See infra notes 80–87 and accompanying text.
5
See, e.g., Illinois Insurance Law Update, AUTISM NEWS NETWORK,
http://www.autismnews.net/insurance.html (last visited Jan. 25, 2016).
6
Id.
7
See M.H. ex rel. P.H. v. N.Y.C. Dep’t of Educ., 685 F.3d 217, 252 (2d Cir. 2012);
Deal ex rel. Deal v. Hamilton Cty. Bd. of Educ., 392 F.3d 840, 861 (6th Cir. 2004); Adams
ex rel. Adams v. Oregon, 195 F.3d 1141, 1149–1150 (9th Cir. 1999).
8
See Illinois Insurance Law Update, supra note 5.
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is a clear division of responsibility with one sector—perhaps the
educational—taking charge and seeing to it that the obligations are, in
fact, discharged.
Part II provides some background information on ASD and its
symptoms. The symptoms are broken down into three categories to
give the reader a sense of the importance of treatment and what the
treatment does, and does not, address. Part III introduces ABA, its role
in treating children with ASD, and its costs. Part IV examines the
extent to which funding for ABA is currently provided through the
educational system. In addition, the case is made for the educational
system to undertake the coordinating aspects of the treatment. Part V
then analyzes the funding options that are available through the
various medical channels. Part VI addresses, and debunks, some of the
claims insurance companies make when denying coverage for ABA and
argues that ABA has defined characteristics of both medicine and
education. ABA is conventional medicine in terms of its ability to
control the core symptoms of ASD and to prevent behavioral sideeffects. That does not, however, take away from the fact that its
methodology and immediate effect are otherwise educational. Finally,
Part VII concludes that despite ABA’s dual-character as both a medical
and educational treatment, more must be done to define the
responsibilities of each, and to relieve the parents of the grueling task
of coming up with the funding for the only viable treatment available
for their child.
II. ASD AND ITS SYMPTOMS
A. What is ASD?
Autism Spectrum Disorder (“ASD”) is an umbrella term used by
the American Psychiatric Association for the diagnosis of a family of
developmental disorders.9 Those disorders are: autistic disorder,
Asperger’s disorder, childhood disintegrative disorder, and pervasive
developmental disorder not otherwise specified (“PDD-NOS”).10
According to Centers for Disease Control and Prevention (“CDC”)
estimates, one in sixty-eight American children—for a total of

9

See
Autism
Spectrum
Disorder,
AM. PSYCHIATRIC PUB.
(2013),
http://www.dsm5.org/Documents/Autism%20Spectrum%20Disorder%20Fact%20S
heet.pdf (outlining the American Psychiatry Association’s revised recommendation,
included in its DSM-5, for a single diagnosis for the four listed disorders).
10
Id.
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4,750,00011—are diagnosed with the disorder.12 In the last fifty years or
so, identification of the disorder has multiplied twenty to thirtyfold,13
with an increase of 123% in the last thirteen years alone.14
“Autism literally means ‘aloneness,’ or living in one’s own
world.”15 The symptoms can range from difficulty in understanding
and relating to other peoples’ perspectives or emotions, to noninteraction with others and treating them as objects.16 As a result, many
autistic children do not develop appropriate social skills and they do
not learn to talk and behave as they should.17
The challenges presented by the disorder vary by the case18 and
can include any number of issues from the following categories: its
core symptoms;19 physical or mental comorbidities;20 and behavioral
problems associated with the disorder.21
11

This figure is based on current estimates of 323 million, as of February 19, 2016.
U.S.
and
World
Population
Clock,
U.S.
CENSUS
BUREAU,
http://www.census.gov/popclock/ (last visited Feb. 19, 2016).
12
Autism and Developmental Disabilities Monitoring (ADDM) Network, CDC,
http://www.cdc.gov/ncbddd/autism/addm.html (last visited Aug. 12, 2015).
13
Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years—Autism and
Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010, CDC (Mar. 28,
2014),
http://www.cdc.gov/mmwr/preview/mmwrhtml/ss6302a1.htm?s_cid=ss6302a1_w.
14
Autism and Developmental Disabilities Monitoring (ADDM) Network, CDC (Aug. 12,
2015), http://www.cdc.gov/ncbddd/autism/addm.html.
15
James B. Adams et al., Advice for Parents of Young Autistic Children (2012, Revised)Part 1, AUTISM RESEARCH INS. (2012), http://www.autism.com/understanding_advice.
This paper was co-authored by Dr. Temple Grandin, a professor of animal science at
Colorado State University and a well-known Autism success story. See Grandin, Temple,
COLORADO STATE UNIVERSITY,
http://ansci.agsci.colostate.edu/people/anscifaculty/grandin-temple/ (last visited September 4, 2016).
16
See Adams et al., supra note 15.
17
Id.
18
See Autism Spectrum Disorder: Signs and Symptoms, CDC (Feb. 21, 2016),
http://www.cdc.gov/ncbddd/autism/signs.html.
19
David J. Posey et al., Developing Drugs for Core Social and Communication Impairment
in Autism, U.S. NAT’L LIBR. OF MED. NAT’L INSTS. OF HEALTH (Oct. 17, 2008),
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566849/
(“Autistic
disorder
(autism) is defined by specific impairments affecting socialization, communication,
and stereotyped behavior which together are called the ‘core symptoms’ of autism.”).
20
See Isaac S. Kohane et al., The Co-Morbidity Burden of Children and Young Adults
with Autism Spectrum Disorders, U.S. NAT’L LIBR. OF MED. NAT’L INSTS. OF HEALTH (Apr.
12, 2012), http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325235/.
21
See Johnny L. Matson & Marie S. Nebel-Schwalm, Assessing Challenging Behaviors
in Children With Autism Spectrum Disorders: A Review, 32 RES. IN DEVELOPMENTAL
DISABILITIES
567,
574
(2007),
available
at
http://www.sciencedirect.com/science/article/pii/S0891422206000734
(noting
that, although most diagnosticians are of the opinion that challenging behaviors are
not core features of ASD, the general consensus is that these maladaptive responses
covary with ASD at a high rate).
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The core symptoms of ASD, from which the diagnosis is derived,
are: (A) “[p]ersistent deficits in social communication and social
interaction across multiple contexts;”22 and (B) “[r]estricted, repetitive
patterns of behavior, interests, or activities.”23 These symptoms are
manifested through mild to severe challenges with thinking, and
learning; impediments to socializing and communicating; and a lack
of agility with regard to interests.24 Moreover, individuals with ASD are
significantly more prone to a host of physical and mental disorders.25
Some examples are: anxiety and mental disorders;26 attention-deficit
22

AM. PSYCHIATRIC ASS’N, DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL
DISORDERS 315.39 (5th ed. 2013), available at https://www.autismspeaks.org/whatautism/diagnosis/dsm-5-diagnostic-criteria. The manual goes on to explain that this
deficit is manifested by the following:
Deficits in social-emotional reciprocity, ranging, for example, from abnormal
social approach and failure of normal back-and-forth conversation; to
reduced sharing of interests, emotions, or affect; to failure to initiate or
respond to social interactions. 2. Deficits in nonverbal communicative
behaviors used for social interaction, ranging, for example, from poorly
integrated verbal and nonverbal communication; to abnormalities in eye
contact and body language or deficits in understanding and use of gestures;
to a total lack of facial expressions and nonverbal communication. 3. Deficits
in developing, maintaining, and understanding relationships, ranging, for
example, from difficulties adjusting behavior to suit various social contexts;
to difficulties in sharing imaginative play or in making friends; to absence of
interest in peers.
Id. at 299.00.
23
The manual indicates that this impairment is manifested by at least two of the
following:
Stereotyped or repetitive motor movements, use of objects, or speech (e.g.,
simple motor stereotypies, lining up toys or flipping objects, echolalia,
idiosyncratic phrases). 2. Insistence on sameness, inflexible adherence to
routines, or ritualized patterns or verbal nonverbal behavior (e.g., extreme
distress at small changes, difficulties with transitions, rigid thinking patterns,
greeting rituals, need to take same route or eat food every day). 3. Highly
restricted, fixated interests that are abnormal in intensity or focus (e.g.,
strong attachment to or preoccupation with unusual objects, excessively
circumscribed or perseverative interest). 4. Hyper- or hyporeactivity to
sensory input or unusual interests in sensory aspects of the environment (e.g.,
apparent indifference to pain/temperature, adverse response to specific
sounds or textures, excessive smelling or touching of objects, visual
fascination with lights or movement).
Id.
24
See CDC, supra note 18.
25
See Kohane et al., supra note 20 (citing the prevalence of these conditions).
26
See Susan W. White et al., Anxiety in Children and Adolescents with Autism Spectrum
PSYCHOL.
REV.
216,
216
(2009),
Disorders,
29
CLINICAL
http://www.sciencedirect.com/science/article/pii/S027273580900004X; Ailsa J.
Russel et al., Cognitive Behavior Therapy for Comorbid Obsessive-Compulsive Disorder in HighFunctioning Autism Spectrum Disorders: A Randomized Controlled Trial, 30 DEPRESSION AND
ANXIETY
697,
697
(2013),
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hyperactivity disorder (“ADHD”);27 gastrointestinal problems;28
epilepsy;29 intellectual30 and learning disabilities;31 motor
abnormalities;32 sensory problems;33 sleep disorders;34 and speech
deficits.35 Perhaps the most visible signs of ASD are those in the third
category—the behavioral. Problematic behavior may include any of
the following:36 aggression, bruxism,37 coprophagy,38 dawdling,
destruction, disruption, drooling, elective mutism, elopement, feces
smearing, food refusal, food theft, genital stimulation, hyperactive
behavior,
hyperventilation,
inappropriate
vocalizations,
noncompliance, pica,39 public disrobing, rapid eating, rectal digging,
http://onlinelibrary.wiley.com/doi/10.1002/da.22053/abstract;jsessionid=16858E3
BFAB9027FAD55FDCB3515F751.f01t03; Susan L. McElroy, Diagnosing and Treating
Comorbid (Complicated) Bipolar Disorder, 15 J. CLINICAL PSYCHIATRY 35, 35 (2004),
http://www.psychiatrist.com/JCP/article/Pages/2004/v65s15/v65s1509.aspx;
Johnny L. Matson & Marie S. Nebel-Schwalm, Comorbid Psychopathology with Autism
Spectrum Disorder in Children: An Overview, 28 RES. IN DEVELOPMENTAL DISABILITIES 341–
52 (2007), http://www.sciencedirect.com/science/article/pii/S0891422206000497.
27
See Angela M. Reiersen & Richard D. Todd, Co-Occurrence of ADHD and Autism
Spectrum Disorders: Phenomenology and Treatment, 8 EXPERT REV. OF NEUROTHERAPEUTICS
657, 657 (2008), http://www.tandfonline.com/doi/full/10.1586/14737175.8.4.657.
28
See Craig A. Erickson et al., Gastrointestinal Factors in Autistic Disorder: A Critical
Review, 35 J. AUTISM AND DEVELOPMENTAL DISORDERS 713, 713 (2005),
http://link.springer.com/article/10.1007%2Fs10803-005-0019-4.
29
See Roberto Tuchman & Isabelle Rapin, Epilepsy in Autism, 1 THE LANCET
NEUROLOGY 352, 352 (2002).
30
See Johnny L. Matson & Mary Shoemaker, Intellectual Disability and its Relationship
to Autism Spectrum Disorders, 30 RES. IN DEVELOPMENTAL DISABILITIES 1107, 1107 (2009),
http://www.sciencedirect.com/science/article/pii/S0891422209000948.
31
M. DAWSON ET AL., LEARNING AND MEMORY: A COMPREHENSIVE REFERENCE 759–72
(2008).
32
See Meng-Chuan Lai et al., Autism, 383 THE LANCET 896, 897 (2014).
33
See Grace T. Baranek, Efficacy of Sensory and Motor Interventions for Children with
Autism, 32 J. AUTISM & DEVELOPMENTAL DISORDERS 397, 398 (2002),
http://link.springer.com/article/10.1023%2FA%3A1020541906063.
34
See Beth A. Malow et al., A Practice Pathway for the Identification, Evaluation, and
Management of Insomnia in Children and Adolescents With Autism Spectrum Disorders, 2
PEDIATRICS 106, 107 (2012).
35
See Ericka L. Wodka et al., Predictors of Phrase and Fluent Speech in Children With
Autism and Severe Language Delay, 131 PEDIATRICS 1128, 1128–34 (2013) (“Autism is a
disorder that significantly affects language/communication skills, with many children
not developing fluent language.”).
36
See McHenry v. PacificSource Health Plans, 679 F. Supp. 2d 1226, 1240 (D. Or.
2010) (quoting Robert H. Horner et al., Problem Behavior Interventions for Young Children
with Autism: A Research Synthesis, 32 J. AUTISM & DEVELOPMENTAL DISORDERS 423, 431
(2002)).
37
Defined as teeth grinding. Id.
38
Defined as feces eating. Id.
39
“The persistent eating of inedible substances, such as dirt or paint that have no
nutritional value.” Mental Health and Pica, WEBMD, http://www.webmd.com/mentalhealth/mental-health-pica (last visited Oct. 21, 2015).
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rumination, self-injurious behavior, tantrum, and tongue protrusion.40
III. TREATMENT AND ABA
A. How is ASD Treated?
There is no known cure for the core symptoms of ASD.41
Treatment is primarily focused on the resultant developmental
impairments.42 “The primary goals of treatment are to minimize the
core features and associated deficits, maximize functional
independence and quality of life, and alleviate family distress.”43 Those
goals are realized through therapy and, to a lesser extent, medication.44
While medication targets adverse behaviors on a temporary basis, only
therapy is effective in the development of positive life skills.45
The therapies necessary for the treatment of ASD range from the
conventional—e.g. occupational and speech—to the ASD specific:
applied behavioral analysis (“ABA”).46 ABA involves painstaking
analysis of behaviors, and weeding out the negative aspects while
encouraging the positive ones.47 The common usage of the term
“ABA” includes a number of different methods and variations, all
based on similar principles.48
40

See McHenry, 679 F. Supp. 2d at 1240.
See Treatment, CDC, http://www.cdc.gov/ncbddd/autism/treatment.html (last
visited Oct. 22, 2015); Scott M. Myers & Chris Plauché Johnson, Management of Children
With Autism Spectrum Disorders, 120 PEDIATRICS 1162, 1162 (2007).
42
McHenry, 679 F. Supp. 2d at 1231 (quoting Patricia Howlin, The Effectiveness of
Interventions for Children with Autism, J. NEURAL TRANSMISSION, Supplement 69, at 101
(2005)).
43
Myers & Johnson, supra note 41; see also Susan E. Levy et al., Autism, 374 THE
LANCET 1627, 1634 (2009) (“Comorbid conditions” in this context refers to both
physical/mental disorders and behavioral problems).
44
See Meng-Chuan Lai et al., supra note 32, at 904.
45
See Michael G. Aman, Medication and Parent Training in Children With Pervasive
Developmental Disorders and Serious Behavior Problems: Results From a Randomized Clinical
Trial, 48 J. AM. ACAD. OF CHILD & ADOLESCENT PSYCHIATRY, 1143–54 (2009).
46
Treatment, CDC, http://www.cdc.gov/ncbddd/autism/treatment.html (last
visited Oct. 22, 2015). The effectiveness of ABA for ASD has created an association
between the two despite the fact that it was not conceived as a treatment for ASD and
is sometimes applied to other disorders. See Karola Dillenburger & Mickey Keenan,
None of the As in ABA stand for Autism: Dispelling the Myths, 34(2) J. INTELL. &
DEVELOPMENTAL DISABILITY 193, 193 (2009).
47
Id; see COOPER et al., APPLIED BEHAVIOR ANALYSIS 16 (2d ed. 1987); Donald M.
Baer et al., Some Current Dimensions of Applied Behavior Analysis, 1 J. APPLIED BEHAV.
ANALYSIS
1,
1
(1968),
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1310980/pdf/jaba00083-0089.pdf
(for what is from the founding documents of the field).
48
Some variations of ABA are: Discrete Trial Training (DTT), Early Intensive
Behavioral Intervention (EIBI), Pivotal Response Training (PRT), Verbal Behavior
41
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B. Effectiveness of ABA for ASD
The studies confirming the efficacy of ABA are conclusive.49
Professional associations,50 courts,51 and administrative agencies52 have
all recognized ABA treatment as the closest to a cure currently
available. As far back as 1999, the Surgeon General declared: “Thirty
years of research demonstrated the efficacy of applied behavioral
methods [for children with autism] in reducing inappropriate
behavior and in increasing communication, learning, and appropriate
social behavior.”53
In a 2007 peer-reviewed report, the American Academy of
Pediatrics, had the following to say about ABA therapy:
The effectiveness of ABA-based intervention in ASDs has been
well documented through 5 decades of research by using
single-subject methodology and in controlled studies . . . .
Children who receive early intensive behavioral treatment have
Intervention (VBI). CDC, supra note 46.
49
“The reliable evidence” as defined by Florida law, conclusively shows that ABA
is not “experimental.” . . . [T]here exists in the medical and scientific literature a
plethora of peer-reviewed meta-analyses, studies, and article that clearly establish ABA
is an effective and significant treatment to prevent disability and restore
developmental skills to children with autism and ASD.” K.G. ex rel. Garrido v. Dudek,
864 F. Supp. 2d 1314, 1326 (S.D. Fla. 2012), aff’d in part & vacated in part, 731 F.3d
1152 (11th Cir. 2013).
50
See, e.g., Scott M. Myers & Chris Plauché Johnson, Management of Children With
Autism Spectrum Disorders, 120 PEDIATRICS 1162, 1164 (2007) (American Academy of
Pediatrics); Eve Glicksman, Catching Autism Early, 43 MONITOR ON PSYCHOL. 56, 56
(2012) (the American Psychological Association, referring to the Early Start Denver
Model (“ESDM”) that incorporates ABA methodology); The Early Start Denver Model
(ESDM), AUTISM SPEAKS, https://www.autismspeaks.org/what-autism/treatment/earlystart-denver-model-esdm (last visited Oct. 25, 2015); see also James B. Adams et al.,
Advice for Parents of Young Autistic Children (2012, Revised)-Part 1, AUTISM RES. INS.,
(2012), http://www.autism.com/understanding_advice (stating that the American
Medical Association recommends the treatment).
51
See, e.g., Dudek, 864 F. Supp. 2d at 1326; McHenry v. PacificSource Health Plans,
679 F. Supp. 2d 1226, 1231 (D. Or. 2010) (internal citation omitted) (listing a host of
supportive studies and stating: “While the degree of ABA’s efficacy is the subject of
current research and debate, ‘[d]ecades worth of scientific research provide clear and
convincing support’ for its use as an ‘effective intervention.’”); Potter v. Blue Cross
Blue Shield, No. 10-cv-14981, 2013 U.S. Dist. LEXIS 119391, at *30 (E.D. Mich. Mar.
30, 2013) (“[W]hat the studies and commentary in the record have in common is the
conclusion that ABA therapy produces clinically proven and statistically significant
positive results for children with autism spectrum disorder.”).
52
See, e.g., CDC, supra note 46; See Autism Spectrum Disorder: Fact Sheet, NAT’L INS. OF
NEUROLOGICAL
DISORDERS
AND
STROKE,
http://www.ninds.nih.gov/disorders/autism/detail_autism.htm#3082_8 (last visited
Oct. 25, 2015).
53
NAT’L INST. OF MENTAL HEALTH, MENTAL HEALTH: A REPORT OF THE SURGEON
GENERAL 164 (1999), https://profiles.nlm.nih.gov/ps/access/NNBBJC.pdf.
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been shown to make substantial, sustained gains in IQ,
language, academic performance, and adaptive behavior as
well as some measures of social behavior, and their outcomes
have been significantly better than those of children in control
groups.54
Likewise, in a report published in the Journal of Clinical Child and
Adolescent Psychology, the authors summarize available peer-reviewed
research and conclude that ABA has been generally proven to provide
significant benefits to individuals with ASD.55 The report analyzes both
Randomized Controlled Trials (“RCTs”)—the gold standard of medical
research56—and replicative studies, finding the general efficacy of the
approach to be well corroborated while suggesting that further
research should be conducted into the tailoring of specific approaches
to individual subjects.57
The overwhelming evidence in ABA’s favor led the experts
testifying in K.G. v. Dudek to declare “that they have never seen a study
in the peer-reviewed literature where the authors concluded that ABA
was ineffective as treatment for children with autism or a study that
characterized ABA as experimental.”58
In a recent study, the authors concluded that “[a]utism spectrum
disorders (ASDs) were once considered lifelong disorders, but recent
findings indicate that some children with ASDs no longer meet
diagnostic criteria for any ASD and reach normal cognitive function.59
54

See Myers & Johnson, supra note 50, at 1164.
See Sally J. Rogers & Laurie A. Vismara, Evidence-Based Comprehensive Treatments
for Early Autism, 37 J. CLINICAL CHILD & ADOLESCENT PSYCHOL. 1, 18–19 (2008); see also
Zachary Warren et al., Therapies for Children With Autism Spectrum Disorders, EFFECTIVE
HEALTH CARE PROGRAM 30–37 (2011) (providing an extensive review of existing
research prepared by Vanderbilt Evidence-based Practice Center for the U.S.
Department of Health and Human Services’ Agency for Healthcare Research and
Quality); Glenn O. Sallows & Tamlynn D. Graupner, Intensive Behavioral Treatment for
Children With Autism: Four-Year Outcome and Predictors, 110 AMER. J. ON MENTAL
RETARDATION 417, 417 (2005).
56
See Gail M. Sullivan, Getting Off the “Gold Standard”: Randomized Controlled Trials
and Education Research, 3 J. OF GRADUATE MED. EDUC. 285 (2011).
57
Id.
58
K.G. ex rel. Garrido v. Dudek, 981 F. Supp. 2d 1275, 1288 (S.D. Fla. 2013).
59
Alyssa J. Orinstein et al., Intervention History of Children and Adolescents with HighFunctioning Autism and Optimal Outcomes, 35 J. OF DEVELOPMENTAL AND BEHAV.
PEDIATRICS 247, 247 (2014). The passage was quoted on account of its use of recoverylike terms, which are more in line with what this author heard from a parent. Although
unclear from the quote to what extent the authors attribute those outcomes to ABA, a
look at the actual study will clear up any uncertainty. The authors assume the
effectiveness of ABA and examine the data in that context. The study is not about
ABA, per se, but about optimal outcomes for ASD in general. See also Ruth Padawer,
The Kids who Beat Autism, N.Y. TIMES MAGAZINE (July 31, 2014),
55
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These children are considered to have achieved ‘optimal outcomes.’”60
The authors then write that the “[optimal outcome] individuals
generally receive earlier, more intense interventions and more ABA.”61
In another study entitled “Early Behavioral Intervention Is Associated
With Normalized Brain Activity in Young Children With Autism,” the
authors, after confirming the efficacy of ABA,62 present data and
conclude that their study “underscores the dynamic and plastic nature
of early brain development in ASD and the potential of early
intervention to alter the course of brain and behavioral development
in young children with ASD and thereby promote the most positive
long-term outcomes.”63
Of course, ABA is not without its detractors. Dr. Ole Ivor Lovaas,
the acknowledged father of ABA’s application to ASD, has taken on
the cherry picking of studies with less impressive results.64 In a 2006
article, he calls for viewing such studies in the context of the whole—
individual studies within a mass of five-hundred.65 Regarding criticism
that ABA encourages robot-like behavior in children, Dr. Lovaas points
out that ABA is progressing to the point where that is no longer the
case.66 Dr. Lovaas also addresses concerns that he has overstated the
results in his original study67 by labeling the results as “recovery.”68 He
points out that he has self-criticized his study and has always called for
rigorous peer-review on his findings.69 The precise degree of
effectiveness should be of limited concern when evaluating a treatment
in isolation. What is important is that it provides a real chance to better
the lives of so many children and their families, which is why it is
currently recommended by so many.70

http://www.nytimes.com/2014/08/03/magazine/the-kids-who-beatautism.html?_r=0.
60
See Orinstein et al., supra note 59.
61
See id.
62
Geraldine Dawson et al., Early Behavioral Intervention is Associated with Normalized
Brain Activity in Young Children with Autism, 51 J. AMER. ACADEMY OF CHILD &
ADOLESCENT PSYCHIATRY 1150, 1150–52 (2012).
63
Id. at 1159.
64
See O.I. Lovaas & Scott Wright, “A Reply to Recent Public Critiques. . .”, 3 J. EARLY
AND INTENSIVE BEHAV. INTERVENTION 234, 234 (2006).
65
Id. Those numbers reflect the reality in 2006, when the article was written. See
Id.
66
Id. at 235.
67
See O. I. Lovaas, Behavioral Treatment and Normal Educational and Intellectual
Functioning in Young Autistic Children, 55 J. CONSULTING & CLINICAL PSYCHOL. 3 (1987).
68
Id.; Lovaas & Wright, supra note 64, at 235.
69
Lovaas & Wright, supra note 64, at 235.
70
See infra note 199 and accompanying text.
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C. The Imperative of Early Intervention
In the realm of ABA, time is of essence.71 The earlier the
treatment begins, the greater the odds of recognizing its full benefit.72
While the facts speak for themselves, a review of the literature suggests
the following assumptions: (1) as the child lives with the condition, bad
behaviors are learned and ingrained;73 (2) “core symptoms of autism
[are] malleable in early childhood;”74 (3) “the neurologic plasticity of
the toddler years affords the best opportunity to attempt fundamental,
broad based behavioral change;”75 (4) once the impediment, ASD, is
contained, age-appropriate development can resume;76 (5) only early
intervention can “alter the course of brain and behavioral
development,”77 or, most importantly; (6) many of the problem
behaviors associated with ASD stem from the frustrating inability of the
child to express himself.78 Teaching the child, at a young age, how to
express himself, renders the cause of those behaviors moot. Regardless
of the psychological or neurobiological reasons behind the
phenomenon, the consensus is clear that the longer a child lives with
ASD, the more the condition progresses and takes root.79
D. The High Cost of Treatment
The cost of effective ABA therapy can be beyond the reach of
many.80 The treatment must be administered by qualified professionals
71

See Eric B. Larsson, Applied Behavior Analysis (ABA) for Autism: What is the Effective
Age Range for Treatment?, THE LOVAAS INS. FOR EARLY INTERVENTION: MIDWEST
HEADQUARTERS (2012), http://www.abia.net.au/images/Larsson-What-is-the-effectiveage-range-of-ABA-for-autism.pdf; see also Glicksman, supra note 50, at 56.
72
See Larsson, supra note 71. Glicksman, supra note 50, at 56.
73
Start Treatment Early—By Age Three!, SYNAPSE: RECONNECTING LIVES,
http://www.autism-help.org/story-early-intervention.htm (last visited Oct. 31, 2015).
74
See Rogers & Vismara, supra note 55, at 20.
75
Gail G. McGee et al., An Incidental Teaching Approach to Early Intervention for
Toddlers with Autism, 24 RES. AND PRAC. FOR PERSONS WITH SEVERE DISABILITIES 133, 135
(1999) (internal citation omitted).
76
See K.G. ex rel. Garrido v. Dudek, 864 F. Supp. 2d 1314, 1319–20 (S.D. Fla. 2012),
aff’d in part & vacated in part, 731 F.3d 1152 (11th Cir. 2013).
77
Dawson et al., supra note 62, at 1159.
78
See Holly Bortfeld, Dealing with Aggression in ASD, TALK ABOUT CURING AUTISM
(Nov. 12, 2012), http://www.tacanow.org/family-resources/dealing-with-aggressionin-asd/. The gender-specific use of “himself” is intentional; according to the CDC,
boys are more likely to be identified with ASD by a ratio of 4.5:1. See Autism and
Developmental
Disabilities
Monitoring
(ADDM)
Network,
CDC,
http://www.cdc.gov/ncbddd/autism/addm.html (last visited on Nov. 4, 2015).
79
See supra notes 71–77.
80
See Deanna L. Sharpe & Dana Lee Baker, Financial Issues Associated with Having
a Child with Autism, 28 J. FAM. AND ECON. ISSUES 247, 248 (2007),
http://pfp.missouri.edu/documents/research/sharpe_financialissues.pdf.
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and with the requisite intensity.81 On average, the treatment costs
more than $29,000 a year.82 Taken together with the other direct and
indirect costs associated with the disorder, the annual cost of ASD can
range anywhere between $77,000 and $173,000.83 Assuming a median
household income of $53,657,84 an ASD diagnosis can amount to
financial devastation. Additionally, parents of autistic children often
have to spend more time with the child, further reducing their income
potential.85 It is most unfortunate when a family must suffer the longterm consequences of missing the ABA window of opportunity86 due to
relatively short-term financial considerations. The high cost of
treatment, without education or medical coverage, translates into
vastly different outcomes based on economic factors, with the brunt of
the effects, predictably, falling upon the indigent.87
IV. SERVICES AVAILABLE THROUGH THE EDUCATIONAL SYSTEM AND
IDEA
One avenue of reprieve is through the educational system and the

81

See id.
The full quote reads as follows:
Direct costs include direct medical costs, such as physician and outpatient
services, prescription medication, and behavioral therapies (estimated to
cost, on average, more than $29,000 per person per year) and direct nonmedical costs, such as special education, camps, and child care (estimated to
annually cost more than $38,000 for those with lower levels of disability and
more than $43,000 for those with higher levels). Indirect costs equal the
value of lost productivity resulting from a person having autism, for example,
the difference in potential income between someone with autism and
someone without. It also captures the value of lost productivity for an autistic
person’s parents. Examples include loss of income due to reduced work
hours or not working altogether. Ganz estimates that annual indirect costs
for autistic individuals and their parents range from more than $39,000 to
nearly $130,000.
Autism Has High Costs to U.S. Society, HARVARD: SCH. OF PUB. HEALTH (Apr. 25, 2006),
http://archive.sph.harvard.edu/press-releases/2006-releases/press04252006.html
(summarizing the findings of recent study).
83
Id.
84
CARMEN DENAVAS-WALT & BERNADETTE D. PROCTOR, U.S. CENSUS BUREAU,
INCOME AND POVERTY IN THE UNITED STATES: 2014 (2015).
85
See Sharpe & Baker, supra note 80. It should be noted that the numbers cited
previously factored in parental wage loss as well as indirect costs. See HARVARD, supra
note 82.
86
See supra notes 71–79 and accompanying text.
87
See Gregory J. Wallance, Autistic Children on Medicaid Missing Out on Crucial
Therapy,
ORLANDO
SENTINEL
(Nov.
14,
2013),
http://articles.orlandosentinel.com/2013-11-14/news/os-ed-medicaid-and-autism111413-20131113_1_therapy-autistic-children-state-medicaid-program.
82
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Individuals with Disabilities Education Act (“IDEA”).88 IDEA is a
federal law that was enacted to ensure educational opportunity for
children with disabilities by setting out detailed steps to be taken by
educational authorities for the identification and remediation of
impediments to learning.89 While Part B of the Act addresses children
with disabilities between the ages of three and twenty-one, Part C
pertains to infants and toddlers, together ensuring some degree of
education for the disabled.90
The mandates of the Act are not limited to the provision of
services that are educational per se, but include what the Act calls related

88

See generally 20 U.S.C. § 1400 (2015).
See Individuals with Disabilities Education Act (IDEA), AMERICAN PSYCHOL. ASS’N,
http://www.apa.org/about/gr/issues/disability/idea.aspx (last visited Oct. 31, 2015).
90
The six principles in Part B are as follows:
(1) Every child is entitled to a free and appropriate public education
(FAPE).
(2) When a school professional believes that a student between the ages of 3
and 21 may have a disability that has substantial impact on the student’s
learning or behavior, the student is entitled to an evaluation in all areas
related to the suspected disability.
(3) Creation of an Individualized Education Plan (IEP). The purpose of the
IEP is to lay out a series of specific actions and steps through which
educational providers, parents and the student themselves may reach the
child’s stated goals.
(4) That the education and services for children with disabilities must be
provided in the least restrictive environment, and if possible, those children
be placed in a “typical” education setting with non-disabled students.
(5) Input of the child and their parents must be taken into account in the
education process.
(6) When a parent feels that an IEP is inappropriate for their child, or that
their child is not receiving needed services, they have the right under IDEA
to challenge their child’s treatment (due process).
Id.
Part C, pertaining to infants and toddlers, contains the following four provisions:
(1) Every family is entitled to appropriate, timely, and multidisciplinary
identification and intervention services for their very young child. These
services must be made available to all families with infants and toddlers.
(2) Families are required to receive an Individualized family Service Plan
(IFSP). This plan lays out the priorities, resources and concerns of the family.
In addition it describes the goals of the child, the services to be provided to
the child, and steps for eventual transitioning of the child into formal
education.
(3) Families have a right to participate in the creation of the IFSP, and must
give consent prior to the initiation of intervention services.
(4) Lastly, parents are entitled to timely resolution of all conflicts or
complaints regarding the evaluation or services provided to their child.
Id.
89
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services, as well.91 The Act defines “related services” to include a host of
therapies and services that are “designed to enable a child with a
disability to receive a free appropriate public education.”92 The
definition goes on to list such services as medical, psychological, and
physical or occupational therapies, among many others.93 The Act
explicitly includes autism in its definitions,94 which, it appears, would
implicate the Act for the provision of ABA therapy either as education
or as related services.
The case law on the subject both endorses and limits the
conclusion that ABA therapy is mandated by the provisions of IDEA.95
While the cases confirm the Act’s inclusion of ABA, they also highlight
the shortcomings of ancillary coverage under what is, at its core, an
educational tool.
In Board of Education v. Rowley, regarding IDEA’s predecessor,96 the
Supreme Court of the United States severely limited the scope of the
Act.97 The Court made clear that the congressional objective was not
to bring out the full potential of the child, but to allow the child to
receive some benefit from the education to which he is already

91

20 U.S.C. § 1401(26) (2015); see also Related Services, CENTER FOR PARENT
INFORMATION AND RESOURCES, http://www.parentcenterhub.org/repository/ieprelatedservices/ (last visited on Oct. 31, 2015).
92
In context, the passage reads as follows:
[Related services shall include] . . . transportation, and such developmental,
corrective, and other supportive services (including speech-language
pathology and audiology services, interpreting services, psychological
services, physical and occupational therapy, recreation, including
therapeutic recreation, social work services, school nurse services designed
to enable a child with a disability to receive a free appropriate public
education as described in the individualized education program of the child,
counseling services, including rehabilitation counseling, orientation and
mobility services, and medical services, except that such medical services shall
be for diagnostic and evaluation purposes only) as may be required to assist
a child with a disability to benefit from special education, and includes the
early identification and assessment of disabling conditions in children.
20 U.S.C. § 1401(26)(A) (2015).
93
Id.
94
20 U.S.C. § 1401(3)(A)(i) (2015).
95
See M.H. ex rel. P.H. v. N.Y.C. Dep’t of Educ., 685 F.3d 217, 252 (2d Cir. 2012); Deal
ex rel. Deal v. Hamilton Cty. Bd. of Educ., 392 F.3d 840, 861 (6th Cir. 2004). See also
Adams ex rel. Adams v. Oregon, 195 F.3d 1141, 1149 (9th Cir. 1999).
96
The ruling regards the Education for All Handicapped Children Act of 1975
(“EHA”), 20 U.S.C. § 1401, which is how IDEA was referred to before the 1990
amendments. See M.H., 685 F.3d at 241 (noting that the court’s decision applies to
IDEA as well).
97
See Bd. of Educ. v. Rowley, 458 U.S. 176, 176 (1982).
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entitled.98 Whereas, before the Act, a disabled child was effectively
denied all access to education, Congress was remedying that situation
and mandating some access.99 In the Court’s opinion, the Act does not
provide for more than “some educational benefit” and the “basic floor
of opportunity” for the child.100
Based on Rowley, many courts have, in fact, denied children the
costly ABA therapy.101 Even courts that do grant consideration of ABA,
allow some consideration of the costs as well.102 In Deal v. Hamilton
County Board of Education, the Court tempered the effects of Rowley and
required that services be designed towards the goal of “meaningful”
benefit and “self-sufficiency” where deemed realistic.103 But Deal
explicitly allowed the school board to factor in costs as well.104
The Rowley ruling, taken together with the cost consideration of
Deal, illustrates the futility of reliance on non-focused media for an
ABA funding solution. A parent would, understandably, want his/her
child’s disabilities to be addressed in its own context, not in the context
of the school’s responsibility to provide a minimal education. For that,
the IDEA comes up short.
There is another potential matter regarding IDEA and ABA that
is worthy of attention. In the statute’s definition of related services,
“medical services” contain the following qualification: “except that
such medical services shall be for diagnostic and evaluation purposes
only.”105 The controlling authority on this definition is the Supreme
Court’s ruling in Cedar Rapids Community School District v. Garret F.106 In
Garret, the Court adopted the United States Secretary of Education’s
definition of “medical services” as “services provided by a licensed
physician.”107 The Court reasoned that this definition “was designed to
spare schools from an obligation to provide a service that might well
prove unduly expensive and beyond the range of their competence.”108
Furthermore, the Court stated that although “Congress plainly

98

Id. at 198, 200–01.
Id. at 191–92, 200.
100
Id. at 200–01.
101
See Deal ex rel. Deal v. Hamilton Cty. Bd. of Educ., 392 F.3d 840, 861–62 (6th Cir.
2004).
102
See id. at 864 (“School districts are permitted to consider cost in devising an
appropriate educational program.”).
103
Id. at 864.
104
See id.
105
20 U.S.C. § 1401(26)(A) (2015).
106
Cedar Rapids Cmty. Sch. Dist. v. Garret F., 526 U.S. 66 (1999).
107
Id. at 74 n.6 (quoting Irving Indep. Sch. Dist. v. Tatro, 468 U.S. 883, 892 (1984)).
108
Id.
99
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required schools to hire various specially trained personnel to help
handicapped children such as trained occupational therapists, speech
therapists, psychologists, social workers,” and although “[s]chool
nurses have long been part of the educational system . . . school
nursing services are not the sort of burden that Congress intended to
exclude as a ‘medical service.’”109 In other words, the Court sees the
IDEA as a vertical expansion of educational services and not a
horizontal one. The schools are required to do more of, or perhaps
better, what they customarily do, but they are not required to expand
the scope of their operations. Even for the provision of “related
services,” schools are not required to change their character and
become multi-faceted providers.
This point is further illustrated in Mary Courtney T. v. School
District.110 In that case, the petitioner sought reimbursement for
services received from a long-term psychiatric residential treatment
center.111 The United States Court of Appeals for the Third Circuit
denied the reimbursement and rejected Garret as a bright-line standard
of whether the service is provided by a physician or not.112 Instead, the
court stated that the focus is on whether the service is within the
traditional competence of a school, regardless of the actual provider.113
As of now, school districts do not decline coverage for ABA on the
grounds that it is a “medical service,” or that it is out of a school’s
traditional competence.114 That may change. As coverage for the
treatment expands under medical plans,115 this argument may become
more credible. Given the costs of ABA, and the legitimacy of such a
consideration both under Rowley116 and Garret,117 there is a real
possibility that, in the future, school boards will start raising such
challenges.
109

Id. at 893 (internal citation and quotation marks omitted).
Mary T. v. Sch. Dist., 575 F.3d 235 (3d Cir. 2009).
111
Id. at 240.
112
Id. at 247.
113
Id. at 247–48. The exact standard introduced by the court is debatable. At one
point, it seems, the court contrasts school services and hospital services. Id. at 247.
Such a standard would create uncertainty where it is arguably neither. Further on, the
court drops the contrast to hospital services and judges whether the service is
traditionally within the educational realm or the “care is far beyond the range of
competence of any public school district . . . .” Id. at 248.
114
See, e.g., BD v. DeBuono, 130 F. Supp. 2d 401, (S.D.N.Y. 2001) (Defendants did not
argue, in defense of their rejection of ABA under IDEA, that the treatment is not,
strictly speaking, educational or related services).
115
As is the current trend. See infra notes 148–149 and accompanying text.
116
See Bd. of Educ. v. Rowley, 458 U.S. 176, 176 (1982).
117
See Cedar Rapids Cmty. Sch. Dist. v. Garret F., 526 U.S. 66 (1999).
110
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This state of affairs underscores the need for an analysis of ABA
itself, whether it is an educational tool or a medical one. To the extent
ABA is inherently educational, it cannot be subjected to standards used
to measure non-educational related services.118 Conversely, if ABA is
inherently medical, it can then be subjected to the Garret standard,
and, given its costs, it may be constrained.
There is, however, a potential role, beyond the direct provision of
ABA, for the educational system to fill. The process of establishing the
correct treatment and procuring the funding—even when the sources
exist—can be tough and drawn out in the best of circumstances. For
a typical parent facing an ASD diagnosis, it is one more source of
confusion among many.119 Making matters worse, the placement of
ABA in the grey area between medicine and education pits the
uninitiated parent against experienced and well-funded insurance
companies and school boards in a fight that should be between
themselves. This is where the school boards should come in.
School boards are well-positioned to take organizational
responsibility for these children within existing frameworks. It should
be incumbent upon them to coordinate the treatment and do what it
takes to secure the funding. Whatever the division of financial
responsibility between them and the insurance companies may be, it
should be the schools that oversee the process. This would be
appropriate for a number of reasons. First, with schools there is always
a distinct entity that cannot defer to others—the school district within
which the child resides. Second, the schools have a personal
relationship with children and their families, and they already evaluate
the children in compliance with IDEA.120 Third, since many of them
do provide ABA to some extent121 they are already involved and familiar
with the field. Even if, under Rowley and Deal,122 the school boards can
escape the full financial burden, they should still see to it that the
children receive the necessary care.
Finally, the IDEA framework already contemplates for schools just
such a role. As mentioned above, under “related services,” the schools
are to provide “medical services, except that such medical services shall

118

See supra notes 105–106 and accompanying text.
See Mari-Jane Williams, Advice for Parents of Children Just Diagnosed with Autism, From
POST
(July
30,
2014),
Those
Who’ve
Been
There,
WASH.
https://www.washingtonpost.com/news/parenting/wp/2014/07/30/advice-forparents-of-children-just-diagnosed-with-autism-from-those-whove-been-there/.
120
See supra note 90.
121
See supra note 95.
122
See supra notes 96–104 and accompanying text.
119
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be for diagnostic and evaluation purposes only.”123 As the Supreme
Court said in Garret, the qualification attached to medical services is
meant to limit the scope of IDEA within each school board’s range of
competence.124 Nevertheless, schools are to provide medical services
for “diagnostic and evaluation purposes.”125 This limited imposition
implies that some degree of general responsibility and charge has been
contemplated for the school districts and has been deemed to be
within their purview. This role should be extended to where it is so
sorely lacking—the coordination of treatment of ASDs.
V. COVERAGE UNDER MEDICAL-PLANS
A. The Coverage Types
Health insurance is another potential source for ABA coverage.
Under our fragmented insurance regime of different payors and
mandates, however, the details can be murky. Additionally, there is
the question of what effects, if any, the Patient Protection and
Affordable Care Act (“ACA”) has on the types of coverage.
By far the biggest coverage cohort is that of private insurance.126
Forty-nine percent of Americans have insurance through their
employer, and an additional six-percent have it through other
means.127 Benefits under private plans are determined, primarily, by
three factors: (1) the specific contractual terms of each plan; (2) state
mandates; and (3) federal mandates, including the ACA.
B. Specific Contractual Terms of Each Plan
An insurance certificate-of-coverage typically includes a list of the
benefit categories covered.128 Following the list of categories is a list of
the types of services excluded despite their potential inclusion within
a benefit category.129 Two of those exclusions are relevant to our
discussion—the exclusion of “not medically necessary” treatments and
of “experimental procedures.”130 ABA therapy would, then, be covered
123

See supra note 92.
See supra notes 107–113 and accompanying text.
125
See supra note 92.
126
See Health Insurance Coverage of the Total Population, HENRY J. KAISER FAM. FOUND.,
http://kff.org/other/state-indicator/total-population/ (last visited Nov. 2, 2015).
127
Id.
128
See, e.g., NJ FamilyCare B, HORIZON BLUE CROSS BLUE SHIELD,
http://www.horizonnjhealth.com/sites/default/files/pdf/Member_Benefits_NJ_Fa
milyCare_B_REV_1-21.pdf (last visited Apr. 20, 2016).
129
See id.
130
Id.
124
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under a “Mental-Health Outpatient Services”131 category, as long as it is
not deemed “not medically necessary” or “experimental.” As it turns
out, it is those clauses, and the argument that ABA is not medicine but
education,132 that the insurance companies invoke to avoid the costly
burden of ABA.133 Most importantly, absent a mandate, the insurer can
skip mental-health altogether,134 exclude ABA specifically,135 or place
caps on those services.136
It should be noted that most denials of coverage are, for the
majority of ASD cases, that the disorder impeded initial development
in the child.137 In about thirty-two percent of cases, however, the
children exhibit development and then regress.138 In those cases,
treatment is restorative and should be covered. Insurance companies,
however, require the parents to provide evidence of the development
that was subsequently lost.139 Ascertaining whether development has
occurred and proving it beyond reasonable deniability is, of course, a
challenge, placing those parents in the same position as the others.
C. Mandates: State and Federal
Historically, health-insurance regulation was a matter left to the
states.140 One significant break from that tradition was the insurance
131

ASD’s characterization as a mental—as opposed to a developmental or neurological—
condition, for the purposes of coverage, is not in doubt. That may be due to its
inclusion in the American Psychological Association’s DSM. See supra note 22; see also
K.G. ex rel. Garrido v. Dudek, 981 F. Supp. 2d 1275, 1292 (S.D. Fla. 2012) (relying on
the DSM for that determination).
132
See infra notes 179–181 and accompanying text.
133
See, e.g. K.G. ex rel. Garrido v. Dudek, 864 F. Supp. 2d 1314, 1315 (S.D. Fla. 2012),
aff’d in part & vacated in part, 731 F.3d 1152 (11th Cir. 2013); McHenry v. PacificSource
Health Plans, 679 F. Supp. 2d 1226, 1228 (D. Or. 2010).
134
See Mental Health Benefits: State Laws Mandating or Regulating, NAT’L CONF. OF ST.
LEGISLATURES,
http://www.ncsl.org/research/health/mental-health-benefits-statemandates.aspx (last visited Nov. 3, 2015).
135
See AUTISM SPECTRUM DISORDERS (ASD): STATE OF THE STATES OF SERVICES AND SUPPORTS FOR
PEOPLE WITH ASD, L & M POL’Y RES. (2014), http://www.medicaid.gov/Medicaid-CHIPProgram-Information/By-Topics/Long-Term-Services-andSupports/Downloads/ASD-State-of-the-States-Report.pdf (providing a comprehensive
state-by-state survey commissioned by CMS).
136
See id.
137
See Katrina Williams et al., Regression in Autism Spectrum Disorder, 51 J. PEDIATRICS AND
CHILD
HEALTH
61,
62
(2015),
http://onlinelibrary.wiley.com/doi/10.1111/jpc.12805/pdf.
138
Id.
139
As communicated to the author by a provider of ABA.
140
See Mila Kofman & Karen Pollitz, Health Insurance Regulation by States and the Federal
Government: A Review of Current Approaches and Proposals for Change, HEALTH POLICY
INSTITUTE,
GEORGETOWN
UNIV.
1
(2006),
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regulatory regime contained in the 1974 Employee Retirement
Income Security Act (“ERISA”).141 The Act goes so far as to preempt
state regulation and to immunize plans against their mandates.142
Although preemption is limited to employer self-funded plans, or
ERISA plans,143 those alone amount to sixty-percent of employer
provided plans.144 That leaves only Medicaid145 and approximately
forty-three percent of private insurance146 subject to state ABA policy.147
Recently, the push for state legislation mandating autism coverage
has picked up.148 Already, thirty-seven states have enacted some form
of mandate covering children with the disorder.149 Additionally, once
a group plan includes coverage for the treatment, it is subject to the
federal Mental Health Parity and Addiction Equity Act (“MHPAEA”)
of 2008.150 That Act prohibits the capping of mental-health services, in
large group or individual plans,151 beyond the caps placed on medical
or surgical procedures.152 However, that prohibition does not affect
small-group employer plans.153 Those plans, on the other hand, are
subject to the ACA mandates.154
D. The Affordable Care Act and its Consequences for ABA
In 2010, Congress enacted the Patient Protection and Affordable
http://www.allhealth.org/briefingmaterials/HealthInsuranceReportKofmanandPolli
tz-95.pdf.
141
29 U.S.C. § 1144 (2013).
142
Id. § 1144(a)–(b).
143
Id.
144
See 2013 Employer Health Benefits Survey, HENRY J. KAISER FAM. FOUND. (2013),
http://kff.org/report-section/ehbs-2013-section-10/.
145
See infra notes 174–179 and accompanying text.
146
The approximate total of all private insurance, taking into account the forty-percent
employer provided and the six-percent other private. See supra notes 126–127 and
accompanying text.
147
The only significant cohort besides those two is Medicare, which pertains to seniors
and is irrelevant to our discussion. See supra note 126.
148
For a fifty-state survey of state ASD mandates, see Insurance Coverage for Autism, NAT’L
CONF. OF ST. LEGISLATURES (2012), http://www.ncsl.org/research/health/autism-andinsurance-coverage-state-laws.aspx.
149
Id.; see also supra note 135.
150
26 U.S.C. § 9812 (2015); 29 U.S.C. § 1185a (2015); 42 U.S.C. § 300gg-5 (2015).
151
The expansion of the MHPAEA to include the individual market was part of the
Affordable Care Act of 2010. See The Mental Health Parity Addiction Equity Act, CTRS. FOR
MEDICARE & MEDICAID SERVS., https://www.cms.gov/CCIIO/Programs-andInitiatives/Other-Insurance-Protections/mhpaea_factsheet.html (last visited Nov. 3,
2015).
152
See id.
153
Id.
154
See infra note 155 and accompanying text.
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Care Act (ACA).155 One of its provisions requires small-group and
individual non-grandfathered plans to cover essential health benefits
(“EHB”).156 EHB are determined by the Secretary of Health and
Human Services (HHS) and must include the following ten-categories:
(A) ambulatory patient services; (B) emergency services;
(C) hospitalization; (D) maternity and newborn care;
(E) mental health and substance use disorder services,
including behavioral health treatment; (F) prescription drugs;
(G) rehabilitative and habilitative services and devices;
(H) laboratory services; (I) preventive and wellness services
and chronic disease management; (J) pediatric services,
including oral and vision care.157
Within these categories, the plans must include all the same
benefits as “a typical employer plan, as determined by the Secretary.”158
In addition, no plans, big or small group, may place lifetime or annual
limits on coverage for the EHB.159
In accordance with the Secretary’s role in determining “typical
employer plan[s],”160 the Centers for Medicare and Medicaid Services
(“CMS”) announced that it will allow states to choose an existing plan,
within limits, to serve as a “benchmark” against which the scope of the
EHB of other plans will be modeled.161 As such, if a benchmark plan
includes coverage for ABA, small-group and individual plans must
include it as well, and neither they, nor large-groups, may place
lifetime or annual limits on it.162 However, limitations as to the quantity
155

42 U.S.C. § 18001 (2015).
42 U.S.C. § 300gg-6(a) (2015).
157
42 U.S.C. § 18022(b) (2015).
158
Id.
159
See Lifetime & Annual Limits, DEP’T HEALTH & HUM. SERVS.,
http://www.hhs.gov/healthcare/about-the-law/benefit-limits/index.html (last visited
Nov. 3, 2015).
160
See supra note 158 and accompanying text.
161
See Information on Essential Health Benefits (EHB) Benchmark Plans, CTR. FOR CONSUMER
INFO.
&
INS.
OVERSIGHT,
https://www.cms.gov/cciio/resources/dataresources/ehb.html.
162
The author has been told that insurers have put forth an argument that inclusion
of ABA in a benchmark plan, if only in compliance with a state-mandate, cannot be
used as a determinant for EHB. Insurers argue that since the coverage is only due to
a mandate, it does not reflect the scope of mental-health or habilitative services in their
plans. However, the CMS bulletin itself seems to negate that argument. In its attempt
to define what a “typical” plan means, CMS presents the prevailing trends regarding
coverage of EHB and states that “[s]tate laws regarding required coverage of benefits
vary widely in number, scope, and topic, so that generalizing about mandates and their
impact on typical employer plans is difficult.” Id. at 7 (emphasis added). This quote
demonstrates that CMS was of the opinion that mandates should impact EHB. That
156
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of the treatment can be imposed equal to the limitations in the
benchmark.163 If ABA is not covered by the benchmark, it can still be
included if the benchmark is missing an entire category that includes
ABA.164 For example, if the benchmark does not include mental-health
or, more likely, habilitative services,165 and ABA falls under that
category, then it may be included.166 The likelihood of ABA’s inclusion
in habilitative services, however, is weak at best. CMS’s proposals for the
definition of the novel category include: parity with rehabilitative
services’ scope of traditional therapies, or a try-your-luck approach.167
Neither of these proposals contemplate an expansion to include the
costly ABA.168
This is not to say that ABA will not, conceivably, in the future, be
mandated as a habilitative service. The Secretary can reverse course
and, pursuant to its authority, include it in the category, as it has
already contemplated.169 In addition, due to the deference awarded
the states by the Secretary, governors can, by declaration, include the

impact was not negative, but positive, and the only impact which would present a
challenge to generalization.
A slightly different version of the same argument may be plausible. If a
benchmark plan does not cover habilitative services at all, as contemplated by CMS, see
id. at 10–11, but does include ABA due to a mandate, insurers may claim that ABA
cannot reflect the scope of habilitative services since the category does not exist.
The relevance of this matter is mostly dependent upon the ultimate question of
whether ABA is educational or medical. Only if ABA is educational would its coverage
depend upon inclusion in habilitative services, otherwise it should be included in mental
and behavioral health. See supra note 157 and accompanying text.
163
See
ObamaCare
Essential
Health
Benefits,
OBAMACARE
FACTS,
http://obamacarefacts.com/essential-health-benefits/ (last visited Nov. 4, 2015).
164
See CTR. FOR CONSUMER INFO. & INS. OVERSIGHT, supra note 161.
165
The phrase “habilitative services” refers to the acquisition of new life-skills. See id. at
11.
166
Id.
167
Id.
168
See Definitions of and Coverage Requirements for “Habilitative Services,” AMER.
OCCUPATIONAL
THERAPY
ASSOC.,
INC.
(2013),
http://www.aahd.us/wpcontent/uploads/2013/02/HabilitSrvcsStDefintionsAOTAFeb2013.pdf (containing a
survey of the definition of habilitative services in thirteen states, only three of which
include ABA; conceivably, even those three only included ABA as a backdoor
mandate).
169
This contemplation is inferred from the discussion of ABA in its EHB bulletin. See
Essential Health Benefits Bulletin, CTR. FOR CONSUMER INFO. & INS. OVERSIGHT (Dec. 16,
2011),
https://www.cms.gov/CCIIO/Resources/Files/Downloads/essential_health_benefits
_bulletin.pdf. There is, however, no indication that such a contemplated mandate
would be under the rubric of habilitative care.
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treatment in the EHB package.170
According to The Kaiser Family Foundation, more than one in
three children are enrolled in either Medicaid or CHIP,171 with
Medicaid being by far the more dominant of the two.172 This lowincome cohort—those without the means of self-financing—are most
vital to our discussion.
In a September 2014, statement, CMS, in response to a question
about whether it mandates coverage for ABA, stated that it does not
endorse or require ABA any more than it does for any “medically
necessary”173 treatment.174 Nonetheless, the statement continued, to
the extent ABA is “medically necessary,” states may no longer refuse
it.175 While some consider this an effective mandate,176 it is only so if
states do not challenge ABA’s status as “medically necessary.”177 CMS
has, however, stated that in the event that states do include the
treatment, the federal government will pay its share as it does with

170

See id.; Joe Guillen, Gov. John Kasich Adds Autism Treatment Services to Ohio’s Health
Insurance
Plans,
CLEVELAND.COM
(Dec.
21,
2012),
http://www.cleveland.com/open/index.ssf/2012/12/gov_kasich_adds_autism_treat
me.html.
171
The Children’s Health Insurance Program (CHIP) that was created to insure
children in families with too high an income to be covered by Medicaid. See Children’s
Health
Insurance
Program
(CHIP),
MEDICAID.GOV,
https://www.medicaid.gov/chip/chip-program-information.html (last visited Apr. 20,
2016).
172
Robin Rudowitz et al., Children’s Health Coverage: Medicaid, CHIP, and the ACA, HENRY
J. KAISER FAM. FOUND. (Mar. 26, 2014), http://kff.org/health-reform/issuebrief/childrens-health-coverage-medicaid-chip-and-the-aca/.
Specifically, twentyeight million children are enrolled in Medicaid and 5.7 million in CHIP. Id.
173
See
Glossary-M,
CTRS.
FOR
MEDICARE
&
MEDICAID
SERVS.,
https://www.medicare.gov/glossary/m.html (last visited Nov. 2, 2015) (defining
“medically necessary” as “[h]ealth care services or supplies needed to diagnose or treat
an illness, injury, condition, disease, or its symptoms and that meet accepted standards
of medicine”).
174
Medicaid and CHIP FAQs: Services to Address Autism, CMS (Sept. 2014),
https://www.autismspeaks.org/sites/default/files/docs/ASLRC/medicaid.cms_faq_
9.24.2014.pdf.
175
Id.
176
Medicaid: States Cannot ‘Delay or Deny’ Autism Treatment, AUTISM SPEAKS (Sept. 29,
2014),
https://www.autismspeaks.org/advocacy/advocacy-news/medicaid-states-cannotdelay-or-deny-autism-treatment.
177
See K.G. ex rel. Garrido v. Dudek, 864 F. Supp. 2d 1314, 1327 (S.D. Fla. 2012)
(mandating Medicaid coverage for ABA prior to the CMS clarification on grounds that
the treatment is not experimental and thus, presumably, medically necessary), aff’d in
part & vacated in part, 731 F.3d 1152 (11th Cir. 2013).
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other Medicaid covered services.178
E. Summary of Potential Coverage Under Medical Plans
The following summarizes the current landscape of medical
coverage and mandates as they apply to ABA: large-group self-funded
plans—ERISA plans—are only affected by the MHPAEA, mandating
parity if it is contractually included; large-group non-ERISA plans are
subject to state-mandates and the MHPAEA; small-group plans are
subject to state-mandates and the ACA, but not the MHPAEA;
individual plans are subject to all three—state-mandates, the ACA, and
MHPAEA. Medicaid, on the other hand, is solely dependent on state
policy. As is apparent, we are far from universal coverage for the vital
ABA by way of mandates alone. This leaves many at the mercy of the
insurance companies and their interpretation of the covered-benefit
terms.
VI. REASONS FOR DENIAL OF COVERAGE ANALYZED
A. Most Common Reasons for Non-Coverage
Insurance companies assert three primary justifications for
declining coverage of ABA: the treatment is not medical, but rather
educational,179 experimental;180 or not medically necessary.181
B. Counter-Arguments in Favor of Coverage
1. Medical or Educational
Insurance companies categorically deny coverage for ABA with
the argument that the treatment is not medical, but rather
educational.182 This argument is not advanced solely by insurance
178

See
CMCS
Informational
Bulletin,
CMS
(July
7,
2014),
http://www.medicaid.gov/Federal-Policy-Guidance/Downloads/CIB-07-07-14.pdf.
179
See
Illinois
Insurance
Law
Update,
AUTISM
NEWS
NETWORK,
http://www.autismnews.net/insurance.html (last visited Jan. 25, 2016).
180
Id.
181
Id.
182
See McHenry v. PacificSource Health Plans, 679 F. Supp. 2d 1226, 1229 (D. Or.
2010); see also State Initiatives, AUTISM SPEAKS, https://www.autismspeaks.org/stateinitiatives (last visited Nov. 4, 2015); Lea Winerman, Autism Diagnoses Bring Slew of Costs
for Families, PBS (Apr. 13, 2011), http://www.pbs.org/newshour/updates/health-janjune11-autismcosts_04-13/; Colleen D. Holland, Note, Autism, Insurance, and the IDEA:
Providing a Legal Comprehensive Legal Framework, 95 CORNELL L. REV. 1253, 1253 (2010).
It is noteworthy that the court in McHenry did not feel that an “educational”
characterization should in itself be grounds for an exclusion. See McHenry, 679 F. Supp.
2d at 1239–40. Instead, it focused on an explicit exception in the plan documents,
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companies refusing coverage, but also by lawmakers.183 After decades
of schools providing the treatment under the IDEA, it is no surprise
that this conception has taken hold.184 The merits of this argument will
be evaluated in the next section.
The question of whether ABA should be regarded as medical or
educational is not merely a matter of semantics—it is about assigning
responsibility for the funding of the sole lifeline available to autistic
children. When there is ambiguity in the very nature of the treatment,
neither sector can be held to account. Any sense of moral obligation
or sympathy an entity would feel is blunted by the presence of another
player. If an insurance company—or a school board for that matter—
can lay the responsibility at somebody else’s doorstep, they are going
to jump at the opportunity. Also, if insurance companies are treated
as reservoirs of funds, imposed upon not when they should be, but when
they can be, they will respond in kind. This leaves the parent in the
precarious situation of having to take on two powerful institutions
without the wherewithal to do so. A definitive characterization of
ABA—as medical or educational—is sorely lacking. Such clarity can
come in the form of an argument that it is one and not the other,
implying that one player should leave the scene, or in the form of a
clear and convincing case that ABA is inherently both medical and
educational. This Comment advocates the latter.
A description for what is considered “medical” can be derived
from the Medicare definition of “medically necessary,” namely:
“[h]ealth care services or supplies needed to diagnose or treat an
illness, injury, condition, disease, or its symptoms and that meet
accepted standards of medicine.”185 “Education,” on the other hand,
as defined in the Merriam-Webster Dictionary, in relevant part, is: “the
knowledge, skill, and understanding that you get from attending a
school, college, or university.”186 In juxtaposition, “medicine” is
retrospective and “education” is prospective. Medicine addresses
and even that was rejected by construing an ambiguity in favor of the insured, as, it
says, should be done for ERISA plans. Id. (citing McClure v. Life Ins. Co, 84 F.3d 1129,
1134 (9th Cir. 1996)).
183
See Insurance Coverage for Autism, NAT’L CONF. OF ST. LEGISLATURES (Aug. 2012),
http://www.ncsl.org/research/health/autism-and-insurance-coverage-state-laws.aspx
(“However, opponents to this approach argue that care for individuals with autism is
the responsibility of parents and the school systems.”).
184
The fact that ABA is required under IDEA, however, is not an indication that it is
educational, since the Act requires related services as well. See supra notes 105–118
and accompanying text.
185
See CTRS. FOR MEDICARE & MEDICAID SERVICES, supra note 173.
186
Education,
MERRIAM-WEBSTER,
http://www.merriamwebster.com/dictionary/education (last visited Nov. 4, 2015).
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complications that arose in the past in order to continue into the
future; education provides for fresh tools and development.
For the sake of analysis, medicine can itself be subdivided into two
subcategories: there are treatments (1) that target core illnesses; and
(2) treatments that target their consequences or side-effects. Cancer
treatments, for example, focus on the removal or containment of the
cancerous cells. Restorative or palliative services, on the other hand,
are focused on the effects of the illnesses and restoration to the extent
possible. ABA has both—containment and restoration.
However, in application, ABA is very much educational. It
“focuses on teaching [c]ore [l]earning [s]kills, [v]erbal [b]ehavior, and
social/play skills.”187 As the court in McHenry points out, ABA is
frequently referred to in educational terms,188 but the means do not
identify the ends.
The goals of ABA are classical medicine. The imperative of earlyintervention, and its rationale, as discussed above,189 are as follows: (1)
bad behaviors are learned and ingrained; (2) the core symptoms are
relatively more malleable early on; (3) the toddler’s brain affords more
potential for change; (4) impediments must be removed early for ageappropriate development to resume; (5) only early intervention can
“alter the course of brain and behavioral development;” or (6) many
of the problem behaviors associated with ASD stem from the lack of
ability to express oneself. These reasons for early intervention indicate
ABA’s twin-objectives: (1) to contain the progression of the disorder
and its symptoms; and (2) to restore natural developmental capacity.190
These two objectives are aligned with the two medical subcategories
discussed above.
ABA can be characterized as containment in the sense that it halts
the progression of the disorder before it establishes itself and becomes
unmanageable—both in terms of the core symptoms and the resulting
behaviors.191 It is restoration as well, in the sense that the teaching of
skills tempers the disorder to allow the restoration of the natural
capacity for development.192 If ASD were a static disorder and therapy
were only necessary for the skills to live with the disorder, ABA can,

187
McHenry v. PacificSource Health Plans, 679 F. Supp. 2d 1226, 1239 (D. Or. 2010)
(internal citation omitted).
188
Id. at 1239–40.
189
See supra notes 71–78 and accompanying text.
190
See supra note 47 and accompanying text.
191
Id.
192
See id.
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conceivably be characterized as merely educational.193 However, that
is not the case.
The fact that early intervention is crucial indicates that there is, in
a sense, effective progression of the disorder. It is that progression that
makes the treatment so important and why it is medically necessary to
treat what is, in effect, a degenerative disease.
Perhaps another way to look at it is in comparison with regressive
ASD. It is well documented that, at times, children begin developing
normally before the ASD takes effect, at which time they begin to
regress.194 In such cases, the treatment is undeniably restorative.195
Ordinary ASDs are fundamentally the same and should be no
different. The fact that regressive ASDs allow for development before
having an effect does not constitute an entirely different disorder.
Instead, regressive ASDs typically allow for some development of the
child’s potential and capacity that is then restored with ABA, while
ordinary ASDs require restoration of the capacity alone, since no
development was allowed to result.
This should not, by any means, undermine ABA’s educational
value; the teaching of skills is classical education as well. The two are
not mutually exclusive. ABA is educational in application and in the
short-term, and medical in result and in the long-term.
2. Experimental
The definition of “experimental” is not that the degree of
effectiveness is in question, but that its entire effectiveness is in

193

Although such analysis is not applied when it comes to traditional therapies.
See Sally Ozonoff et al., The Onset of Autism: Patterns of Symptom Emergence in the First
INSTS.
OF
HEALTH
1
(2008),
Years
of
Life,
NAT’L
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857525/pdf/nihms-118847.pdf.
195
See AUTISM NEWS NETWORK, supra note 179.
194
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question.196 As quoted extensively above,197 ABA easily surpasses that
minimal threshold. The court in Dudek gave this matter considerable
attention and ruled, in no uncertain terms, that ABA is not
experimental, and that a determination to the contrary is “arbitrary,
capricious, and unreasonable.”198 The court quoted the testimony of
doctors that ABA “is the standard means of treatment for autism;” that
“it would be medical malpractice not to prescribe ABA for a child with
autism;” and that ”the consensus in the medical community is that ABA
has been the standard means of treatment for children with autism and
ASD since the 1990’s, evidenced by consensus statements from [a
plethora of prominent medical authorities].”199 The proceedings in
Dudek demonstrated the existence of an abundance of “peer-reviewed
meta-analyses, studies, and articles that clearly establish” the efficacy of
ABA as a treatment “to prevent disability and restore developmental
skills to children with autism and ASD” including “findings of large to
moderate changes in IQ . . . effects in terms of intellectual functioning,
language development, acquisition of daily living skills, and social
functioning in children with autism and ABA . . . .”200 “Notably,” the
196

This can be inferred from the language itself. See, e.g., Potter v. Blue Cross Blue
Shield, No. 10-cv-14981, 2013 U.S. Dist. Lexis 119391, at *9 (E.D. Mich. Mar. 30, 2013)
(interpreting the following definition of experimental: “[m]edical literature or clinical
experience is inconclusive as to whether the service is safe or effective for treatment of
any condition, or [the service] has been shown to be safe and effective treatment for
some conditions, but there is inadequate medical literature or clinical experience to support
its use in treating the patient’s condition.”) (internal citations omitted); see also NJ
FamilyCare B, supra note 128 (excluding “[e]xperimental procedures, or procedures
not accepted as being effective, including experimental organ transplants[,]” equating
experimental with “not accepted as being effective”). This conclusion comports, as
well, with common sense: the vast-majority of medical procedures lack guaranteed
effectiveness, and some have a fairly low likelihood of success, and yet no one denies
payment for those treatments because they are experimental. See Eric V. Larsson,
Intensive Early Intervention using Behavior Therapy is the Single Most Widely Accepted
Treatment for Autism, LOVAAS INST. FOR EARLY INTERVENTION (2008),
http://www.wncbest.org/fileadmin/user_upload/ieibt-Lovaas.pdf (“The total cure
rates and effective treatment rates for early intervention for autism are comparable to
those of most medically accepted treatments.”).
197
Supra notes 49–63 and accompanying text.
198
See K.G. ex rel. Garrido v. Dudek, 864 F. Supp. 2d 1314, 1321–27 (S.D. Fla. 2012),
aff’d in part & vacated in part, 731 F.3d 1152 (11th Cir. 2013).
199
Id. at 1326. The quoted testimony referred to statements issued by the Centers for
Medicare and Medicaid Services, the United States Surgeon General, the Center for
Disease Control and Prevention, the National Institute for Child Health and Human
Development, the National Institute for Neurological Disorders and Stroke, the
National Institute for Mental Health, the American Society of Child and Adolescent
Psychiatry, the American Academy of Pediatrics, and the American Psychological
Association. Id.
200
Id.
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court continued, “all the experts that testified for Plaintiffs and
Defendant stated that they have never seen a study in the peerreviewed literature where the authors concluded that ABA was
ineffective as a treatment for children with autism or a study that
characterized ABA as experimental.”201
3. Medical Necessity
The definition of “medically necessary” provided by Medicare is
as follows: “[h]ealth care services or supplies needed to diagnose or
treat an illness, injury, condition, disease, or its symptoms and that
meet accepted standards of medicine.”202 This defense, as opposed to
the first one, takes for granted the treatment’s original
characterization as a medical treatment. Instead, it probes its relative
necessity to the patient in question. Regarding ABA, as long as ASD is
either an “illness, injury, condition, or disease” and ABA meets
“accepted standards of medicine,” it clears this threshold. ASD is
certainly an “illness, injury, condition, or disease,” so that leaves us to
figure out whether it meets the “accepted standards of medicine.” This
question is, effectively, subsumed by the second defense—it is
experimental.203 As stated above,204 ABA is by consensus the standard
treatment for ASDs, hence, it falls well within the “accepted standards
of medicine.” If autism is a “condition,” and the treatment, when
prescribed by a physician, is consistent with standard medical-practice,
it is, by definition, medically necessary.
VII. CONCLUSION
The scientific approach—with its evidence-based methods—does
not convey a sense of the overwhelming success of ABA
methodology.205 The more unrestrained testimony comes from those

201

Id. at 1327; see also Potter, 2013 U.S. Dist. LEXIS 119391, at *17 (“[T]he Court finds
that BCBS’s denial-of-benefits for ABA therapy on the grounds that such therapy is
experimental or investigative was arbitrary and capricious.”); McHenry v.
PacificSource Health Plans, 679 F. Supp. 2d 1226, 1237 (D. Or. 2010) (“Based upon a
thorough examination of the record, this court concludes that the weight of the
evidence demonstrates that ABA therapy is firmly supported by decades of research
and application and is a well-established treatment modality of autism and other PDDs.
It is not an experimental or investigational procedure.”).
202
See CTRS. FOR MEDICARE & MEDICAID SERVICES, supra note 173.
203
See K.G. ex rel. Garrido v. Dudek, 864 F. Supp. 2d 1314, 1320 (S.D. Fla. 2012)
(addressing “medically necessary” and “experimental” as one), aff’d in part & vacated
in part, 731 F.3d 1152 (11th Cir. 2013).
204
See supra note 199 and accompanying text.
205
See Lovaas & Wright, supra note 64.
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not bound by scientific conventions—the parents.206 It is not
uncommon to hear parents exclaim that through ABA, “I’m getting
my child back.”207 One woman, the host of a program on autism, refers
to the treatment as “the autism miracle in my living room.”208 Other
parents describe the therapy as “nothing short of a miracle,” as they
saw “huge improvements even in areas that were not set as goals,” or
saw their son “now attending high school and . . . fully integrated in
General Ed.”209 Another child with a “classic” diagnosis of ASD, after
two-years of extensive ABA therapy, was deemed cured, leaving the
parents as “[shocked] as when he was diagnosed,” saying, “[w]e didn’t
even know recovery was a possibility.”210
The financial burden of ABA is indeed heavy,211 but casting off the
burden is no solution. According to one study, the savings to society
from treating ASD with ABA is estimated to be between $2,439,710 and
$2,816,535 before the age of fifty-five alone.212 In reality, the costs in
premium increases for ABA inclusion are only about three-tenths of
one-percent.213 The long-term benefit to society from the relatively
short-term, and timely, treatment, is well worth the cost.
Unfortunately, the current state of coverage for ABA is porous at
best. The educational system is only obligated to provide for minimal
results, and even then is allowed to factor in cost. State-mandated
medical coverage, even in those states that impose them, only covers
non-ERISA plans and perhaps Medicaid. The federal MHPAEA is
hardly a factor since it only regulates the limits of already existing
206

See HARVARD, supra note 82.
The
Autism
Miracle
in
my
Livingroom,
ABA
(Jan.
27,
2011),
https://autismmiracles.wordpress.com/2011/01/27/aba/.
208
Id. The program is accessible on iTunes, and the program on ABA in particular is
at:
https://itunes.apple.com/us/podcast/aba-therapy-forautism/id356451530?i=117605530&mt=2.
209
Client Testimonials: What are Satisfied Parents Saying About Their Experiences With Positive
ABA, POSITIVE ABA, http://www.positiveaba.org/about-us/client-testimonials/ (last
visited Oct. 27, 2015). The author is aware of the inherent unreliability of customer
testimonials; nevertheless, a representative sample is in order to develop a sense of the
real-life reception to this approach. Ideally, there would be no biased non-scientific
sources in an academic paper. However, the purpose is not to convince the reader
with these quotes, but to inspire further examination.
210
Shirley S. Wang, Who Can Outgrow or Recover From Autism, WALL ST. J. (Jan. 21, 2013),
http://www.wsj.com/articles/SB1000142412788732330110457825572188737238.
211
See HARVARD, supra note 82.
212
See AUTISM SPEAKS, AUTISM SPEAKS SUBMISSION TO THE PENNSYLVANIA HEALTH CARE
COST
CONTAINMENT
COUNCIL
17
(2007),
https://www.autismspeaks.org/docs/gr/HC4_testimony.pdf.
213
See CTR. FOR CONSUMER INFO. AND INS. OVERSIGHT, supra note 169, at 7.
207
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coverage. Likewise, the much heralded ACA is of little consequence,
since, by all indications, it is not being construed as a meaningful
expansion in this area. Insurance companies have resorted to dubious
claims to avoid coverage—e.g., the treatment is “not medically
necessary” or is “educational.” Worst of all, it is the parents, at their
most vulnerable state and where time is of essence, that are left to take
on these powerful interests.
ABA has within it elements of education and elements of
medicine, and the two should be sharing the burden. However, as long
as the burdens are not clearly defined, with a definitive and
recognizable apportionment of the responsibility, neither will
voluntarily undertake more than absolutely required. Whether the
solution should be fractional apportionment or by milestone, the
parents are ill-equipped and unlikely to be effective in the imposition
of a solution. As mentioned earlier, it is the school boards that are
equipped and in the position to take control and see to it that the
children do in fact receive the care that they so vitally require. This
can be accomplished within the IDEA framework and with minimal, if
any, legislative input. It is imperative that these children receive the
help that they need, and no less important, when they need it.

